InMode Ltd. (INMD) Fair Value 2026

INMD · Electromedical & Electrotherapeutic Apparatus ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

9.9 /10

32 fundamental signals · 12 models active

Value Trap Risk

SAFE (8/100)

Quick Summary — As of 2026-07-13, InMode Ltd. (INMD) trades at $15.15, approximately 55% below CirclFi’s Bayesian DCF fair value of $33.61. QOC: 9.9/10. Value Trap Risk: 8/100 (SAFE). 12/13 models active.

Key Facts

Ticker
INMD
Price
$15.15
Quality Score
9.9/10
Value Trap Risk
8/100
Models Active
12/13
Last Updated
Strength: Bayesian DCF suggests +121.8% upside with 51% confidence
Risk: Limited model coverage (12/13) may reduce confidence

Valuation Matrix

12 Intrinsic Value Models vs. Current Price ($15.15)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
High Conviction
$33.61 +121.8%
Earnings Power Value
High Conviction
$19.99 +32.0%
CUCE Ensemble
Low Conviction
$27.99 +84.7%
First Chicago
Medium Conviction
$20.73 +36.8%

Unlock the Full Matrix

Access 8 additional models including EROIC Spread, ML-RIV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 12 Models →

Cancel anytime · No contracts · Instant access

What Is InMode Ltd. (INMD) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, InMode Ltd.'s intrinsic value is estimated at $26.47, suggesting a +74.7% average upside from the current price of $15.15. While 8 models see room for appreciation, model agreement is not unanimous as 3 models flag potential overvaluation. Model dispersion is worth noting: Regime Cross targets $75.36 (+397.4%), versus Dynamic NAV at $7.47 (-50.7%). This +448.1% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About INMD?

12 of 13 models are currently active for INMD. Of these, 8 models suggest upside while 4 models suggest overvaluation. The Bayesian DCF estimates INMD's intrinsic value at $33.61, implying +121.8% upside from the current price. See which stocks rank higher →

How Does INMD Rank in Electromedical & Electrotherapeutic Apparatus?

Among 25 Electromedical & Electrotherapeutic Apparatus stocks, INMD ranks #1 by Quality of Company score. CirclFi's QOC score of 9.9/10 evaluates 32 fundamental signals. A score of 9.9 places INMD in the top tier.

InMode Ltd. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is INMD a Value Trap?

CirclFi's Value Trap algorithm assigns INMD a score of 8/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

12 of 13 models are active for InMode Ltd.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, InMode Ltd. earns a quality score of 9.9/10. This exceptional rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +448.1% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every INMD valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across INMD's 12 active models, average confidence is 36%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy InMode Ltd. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Electromedical & Electrotherapeutic Apparatus Stocks Should You Also Analyze?

8 related Electromedical & Electrotherapeutic Apparatus stocks with 13-model coverage

Read investment analysis: ELMD · LIVN · CNMD · ITGR · MDT

Frequently Asked Questions About InMode Ltd.

What is InMode Ltd.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, InMode Ltd. (INMD) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $33.61. The Quality of Company score is 9.9/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is INMD overvalued or undervalued right now?

At $15.15, 8 of 12 active models suggest INMD may be undervalued, while 4 indicate potential overvaluation. The assessment depends on which methodology best fits InMode Ltd.'s business model in Electromedical & Electrotherapeutic Apparatus.

What does a Quality of Company score of 9.9 mean for INMD?

InMode Ltd.'s QOC of 9.9/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on INMD?

CirclFi analyzes INMD with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 12 of 13 are active for this stock. Read the full methodology →

Is INMD a value trap in 2026?

InMode Ltd.'s Value Trap score is 8/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 12 mathematical frameworks give you clarity on INMD.

Unlock All 12 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access